Clinical Trial Update: gliomasPCV Only in 1p/19q Codeleted Anaplastic Gliomas [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating PCV chemotherapy (procarbazine, lomustine, and vincristine) in patients with Anaplastic glioma with 1p/19q codeletion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Glioma

Drugs mentioned

• Lomustine (CCNU) (lomustine)
• Procarbazine (procarbazine)
• Vincristine (vincristine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Anaplastic Gliomas With 1p/19q Codeletion | Phase 3 | Status: COMPLETED